News XORTX Therapeutics Inc.

Equities

XRTX

CA98420Q3061

Market Closed - Toronto S.E. Other stock markets 03:02:08 2024-04-19 pm EDT			5-day change	1st Jan Change
4.07 ^CAD	-4.01%		-9.56%	+40.34%

Apr. 08	XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors	CI
Apr. 03	XORTX Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

XORTX Welcomes New Member to the Board of Directors	Apr. 08	AQ
XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors	Apr. 08	CI
XORTX Announces Participation in Spring 2024 Investor Conferences	Apr. 08	AQ
XORTX Therapeutics : CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K	Apr. 04	PU
XORTX Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 02	CI
XORTX Announces New Clinical Advisory Board Member	Mar. 28	AQ
XORTX Announces New Clinical Advisory Board Member	Mar. 27	AQ
XORTX Therapeutics Inc. Appoints Ronald Perrone as Clinical Advisory Board	Mar. 27	CI
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial	Mar. 19	AQ
XORTX Therapeutics Provides Update	Mar. 19	MT
XORTX Therapeutics Brief: Has Highlighted "Achievements" of 2023 and Preparations for Registration Clinical Trial	Mar. 19	MT
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial	Mar. 19	AQ
XORTX Therapeutics : Investor Presentation	Mar. 05	PU
MONEY TALK RADIO with XORTX Therapeutics Inc. (NAS:XRTX) Dr. Allen Davidoff Explains Advanced Drug Therapy for Kidney Disease and Diabetes	Mar. 03	AQ
MONEY TALK RADIO with XORTX Therapeutics Inc. (NASDAQ:XRTX) Dr. Allen Davidoff Explains Advanced Drug Therapy for Kidney Disease and Diabetes	Mar. 03	AW
XORTX Therapeutics Inc. announced a financing transaction	Feb. 14	CI
XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units	Feb. 01	GL
XORTX Announces $2 Million Public Offering	Jan. 16	AQ
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease	Jan. 03	MT
XORTX Therapeutics Inc. Submits New Patent for the Treatment of Chronic Kidney Disease	Jan. 03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News XORTX Therapeutics Inc.

Equities

XRTX

CA98420Q3061

Summary

Filters